{
  "task_type": "needs_assessment",
  "topic": "Type 2 Diabetes Management: Updates in Pharmacotherapy and Lifestyle Interventions",
  "compliance_mode": "auto",
  "target_audience": "Primary Care Physicians",
  "funder": "American Diabetes Association",
  "word_count_target": 1250,
  "moore_levels": [
    "level_3_learning_declarative",
    "level_4_competence",
    "level_5_performance"
  ],
  "include_sdoh": true,
  "include_equity": true,
  "reference_count_min": 8,
  "reference_count_max": 12,
  "additional_context": {
    "focus_areas": [
      "Recent guideline updates",
      "GLP-1 receptor agonists",
      "SGLT2 inhibitors",
      "Cardiovascular risk reduction",
      "Health equity considerations"
    ],
    "target_credit_hours": 1.0
  }
}
